Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells (Q39629347)

13 September 2017

title

Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells (English)

1 reference

Ángeles O Angela Ruiz-Extremera

13 September 2017

1 reference

1 reference

3

object named as

A. Ruiz-Extremera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093979

31 August 2024

8

F. J. Oliver

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093979

31 August 2024

author name string

Laura Sanjuan-Nuñez

5

1 reference

13 September 2017

Josefa León

7

1 reference

13 September 2017

J. A. Muñoz-Gámez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093979

31 August 2024

R. Quiles-Pérez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093979

31 August 2024

A. B. Martín-Álvarez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093979

31 August 2024

A. Carazo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093979

31 August 2024

J. Salmerón

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093979

31 August 2024

language of work or name

English

0 references

publication date

19 November 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0304383510005112?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

https://api.elsevier.com/content/article/PII:S0304383510005112?httpAccept=text/plain

31 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

31 August 2024

1 reference

13 September 2017

volume

301

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

47-56

1 reference

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Long-term outcome of resection of large hepatocellular carcinoma

31 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Molecular targeted therapies in hepatocellular carcinoma

31 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer

31 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation

31 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

31 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation.

31 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression

31 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.

31 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Expression of poly(ADP-ribose) polymerase in human hepatocellular carcinoma and analysis of biopsy specimens obtained under sonographic guidance

31 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Chemopotentiation by PARP inhibitors in cancer therapy.

31 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

31 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016.

31 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

DNA vector-based RNAi approach for stable depletion of poly(ADP-ribose) polymerase-1.

31 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.

31 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation

31 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Biología celular y genética en el cáncer de hígado

31 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models

31 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints.

31 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

31 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity

31 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury

31 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injury

31 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.

31 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

31 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Shock, inflammation and PARP.

31 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

31 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation

31 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells

31 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Hepatocellular carcinoma pathogenesis: from genes to environment

31 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

31 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

High poly(adenosine diphosphate-ribose) polymerase expression and poor survival in advanced-stage serous ovarian cancer

31 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane.

31 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation

31 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Inhibition of Poly(ADP-Ribose) Polymerase Modulates Tumor-Related Gene Expression, Including Hypoxia-Inducible Factor-1 Activation, during Skin Carcinogenesis

31 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

Parp-1 deficiency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice

31 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.10.026

31 August 2024

Identifiers

1 reference

13 September 2017

1 reference